Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction. Conference Paper uri icon

Overview

abstract

  • The level of CYP2D6 metabolic activity can be predicted by pharmacogenomic testing, and concomitant use of clinical decision support has the potential to prevent adverse effects from those drugs metabolized by this enzyme. Our initial findings after implementation of clinical decision support alerts integrated in the electronic health records suggest high feasibility, but also identify important challenges.

publication date

  • January 1, 2015

Research

keywords

  • Cytochrome P-450 CYP2D6
  • Decision Support Systems, Clinical

Identity

Scopus Document Identifier

  • 84952011706

PubMed ID

  • 26262248

Additional Document Info

volume

  • 216